Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Hong Kong
  4. Hong Kong Stock Exchange
  5. Sinopharm Group Co., Ltd.
  6. Summary
    1099   CNE100000FN7

SINOPHARM GROUP CO., LTD.

(1099)
  Report
 SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Hong Kong Stock Exchange
06/07/2021 06/08/2021 06/09/2021 06/10/2021 06/11/2021 Date
27.85 26.3 26.5 26.1 26 Last
12539810 10508600 3073559 7616483 4381934 Volume
+4.90% -5.57% +0.76% -1.51% -0.38% Change
Financials
Sales 2021 527 B 82 307 M 82 307 M
Net income 2021 8 067 M 1 260 M 1 260 M
Net Debt 2021 16 870 M 2 634 M 2 634 M
P/E ratio 2021 8,28x
Yield 2021 3,52%
Sales 2022 587 B 91 697 M 91 697 M
Net income 2022 8 848 M 1 382 M 1 382 M
Net Debt 2022 14 891 M 2 325 M 2 325 M
P/E ratio 2022 7,60x
Yield 2022 3,98%
Capitalization 66 876 M 10 453 M 10 443 M
EV / Sales 2021 0,16x
EV / Sales 2022 0,14x
Nbr of Employees 108 316
Free-Float 43,0%
More Financials
Company
Sinopharm Group Company Limited is principally engaged in the distribution of pharmaceutical products and medical equipment. The Company operates through three business segments. The Pharmaceutical Distribution segment is engaged in the distribution of medicines, medicine devices and pharmaceutical products to hospitals, other distributors, retail drug stores and clinics. The Retail Pharmacy segment is engaged in... 
More about the company
Ratings of Sinopharm Group Co., Ltd.
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
C
More Ratings
All news about SINOPHARM GROUP CO., LTD.
06/15SINOPHARM GROUP CO., LTD. : Ex-dividend day for final dividend
FA
06/09China to study using CanSinoBIO COVID shots as a booster
RE
06/08Boyu, Sinopharm among bidders shortlisted for Mundipharma China - sources
RE
06/04Who senior adviser says having "very positive" conversations with sinovac an..
RE
06/02MARKET CHATTER : Sinopharm Can Supply Over 1 Billion COVID-19 Vaccines in H2, Ch..
MT
06/02Bahrain, Facing a Covid Surge, Starts Giving Pfizer Boosters to Recipients of..
DJ
06/02Bahrain Residents Who Are Over 50, Obese, Have Chronic Illnesses Urged To Get..
RE
06/02Bahrain residents who are over 50, obese, have chronic illnesses urged to get..
RE
06/01SINOPHARMá : WHO Grants Emergency-Use Approval to Sinovac's COVID-19 Vaccine
MT
06/01WHO Urges More Funding From Rich Nations for Covid Vaccines, Endorses Sinovac..
DJ
06/01Foreign Governments Request Covid-19 Vaccine Doses as U.S. Prepares to Share ..
DJ
06/01Foreign Governments Request Covid-19 Vaccine Doses as U.S. Prepares to Share
DJ
06/01WHO approves Sinovac COVID shot in second Chinese milestone
RE
05/31Sinopharm's Wuhan affiliate boosts COVID-19 shot annual capacity to 1 billion..
RE
05/31MARKET CHATTER : Hungary Plans $193 Million Plant to Produce Sinopharm COVID-19 ..
MT
More news
News in other languages on SINOPHARM GROUP CO., LTD.
06/08COVID : la Chine se prépare à vacciner les enfants dès 3 ans
06/06CORONA-BLOG/Spahn weist Vorwürfe zu Masken für Obdachlose zurück
06/06CORONA-BLOG/Gesundheitsministerium will Vergütung für Tests senken
06/06CORONA-BLOG/Inzidenz fällt unter 25
06/05CORONA-BLOG/Delta-Variante könnte Lage wieder verschärfen
More news
Chart SINOPHARM GROUP CO., LTD.
Duration : Period :
Sinopharm Group Co., Ltd. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends SINOPHARM GROUP CO., LTD.
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 18
Average target price 23,87 CNY
Last Close Price 21,43 CNY
Spread / Highest target 38,8%
Spread / Average Target 11,4%
Spread / Lowest Target -19,9%
EPS Revisions
Managers and Directors
NameTitle
Yong Liu President & Executive Director
Xiao Juan Li Chief Financial Officer
Fang Yao Chairman-Supervisory Board
Qing Ming Yu Chairman
Wu Ping Tao Member-Supervisory Board
Sector and Competitors
1st jan.Capitalization (M$)
SINOPHARM GROUP CO., LTD.37.86%10 453
WALGREENS BOOTS ALLIANCE, INC.38.69%47 049
JD HEALTH INTERNATIONAL INC.-27.87%44 388
MCKESSON CORPORATION10.92%29 837
CARDINAL HEALTH, INC.10.74%16 924
HUADONG MEDICINE CO., LTD80.27%13 094